Metoprolol Tartrate And Hydrochlorothiazide



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 53.8%
Type 2 Diabetes Mellitus 11.5%
Osteoporosis 7.7%
Angiopathy 3.8%
Cardiovascular Event Prophylaxis 3.8%
Dementia 3.8%
Depression 3.8%
Neuropathy Peripheral 3.8%
Peripheral Arterial Occlusive Disease 3.8%
Urge Incontinence 3.8%
Presyncope 14.3%
Bradycardia 7.1%
Drug Ineffective 7.1%
Drug Interaction 7.1%
Eye Movement Disorder 7.1%
Hypoglycaemia 7.1%
Hyponatraemia 7.1%
Loss Of Consciousness 7.1%
Shock Hypoglycaemic 7.1%
Speech Disorder 7.1%
Syncope 7.1%
Toxic Skin Eruption 7.1%
Vomiting 7.1%
Secondary
Hypertension 25.5%
Product Used For Unknown Indication 23.4%
Coronary Artery Disease 11.7%
Accidental Exposure 5.8%
Drug Use For Unknown Indication 5.8%
Depression 4.4%
Benign Prostatic Hyperplasia 2.9%
Cardiac Failure 2.9%
Osteoporosis 2.9%
Atrial Fibrillation 2.2%
Angiopathy 1.5%
Bipolar Disorder 1.5%
Diabetes Mellitus 1.5%
Hyperlipidaemia 1.5%
Sepsis 1.5%
Thyroid Disorder 1.5%
Type 2 Diabetes Mellitus 1.5%
Arthritis 0.7%
Goitre 0.7%
Knee Arthroplasty 0.7%
Dry Mouth 13.8%
Completed Suicide 10.3%
Death 10.3%
Blood Pressure Diastolic Decreased 6.9%
Overdose 6.9%
Accidental Exposure 3.4%
Aphasia 3.4%
Asthenia 3.4%
Decubitus Ulcer 3.4%
Epistaxis 3.4%
Fall 3.4%
Haemarthrosis 3.4%
Hypotension 3.4%
Intentional Drug Misuse 3.4%
Paraesthesia 3.4%
Pyrexia 3.4%
Tachyarrhythmia 3.4%
Thyroid Disorder 3.4%
Toxicity To Various Agents 3.4%
Tremor 3.4%
Concomitant
Product Used For Unknown Indication 38.4%
Hypertension 16.4%
Atrial Fibrillation 5.5%
Pain 4.9%
Parkinson's Disease 3.6%
Osteoporosis 2.7%
Prophylaxis 2.5%
Renal Transplant 2.5%
Diabetes Mellitus 2.4%
Type 2 Diabetes Mellitus 2.4%
Coronary Artery Disease 2.2%
Nausea 2.2%
Rheumatoid Arthritis 2.2%
B-cell Lymphoma 1.8%
Blood Cholesterol Increased 1.8%
Multiple Myeloma 1.8%
Pharyngitis 1.8%
Depression 1.6%
Head And Neck Cancer 1.6%
Non-small Cell Lung Cancer 1.6%
Weight Decreased 12.0%
Cardiac Disorder 8.0%
Haemorrhage Intracranial 8.0%
Cardiac Failure 6.0%
Drug Interaction 6.0%
Aggression 4.0%
Ascites 4.0%
Breast Cancer 4.0%
Cerebral Infarction 4.0%
Dyspnoea 4.0%
Erysipelas 4.0%
Flushing 4.0%
Haemoglobin Decreased 4.0%
Hypertensive Crisis 4.0%
Ischaemic Stroke 4.0%
Leukopenia 4.0%
Pancytopenia 4.0%
Parkinson's Disease 4.0%
Pharyngeal Oedema 4.0%
Post Procedural Infection 4.0%